Laos Government Plans to Classify E-cigarettes as Addictive Substances

Regulations by 2FIRSTS.ai
Nov.30.2023
Laos Government Plans to Classify E-cigarettes as Addictive Substances
Laos plans to include e-cigarettes in its list of addictive substances due to the increasing prevalence among youth.

According to a report by Xinhua News Agency on November 30th, the Laotian government plans to amend and supplement certain provisions of the drug prevention and control law, including the inclusion of e-cigarettes in the list classified as addictive substances and precursors.

 

During the sixth regular session of the ninth Lao National Assembly, Deputy Prime Minister and Minister of Public Security Vilay Lakhamfong emphasized that e-cigarettes, which are one of the emerging issues of social concern, have not yet been included in Laos' list of prohibited items.

 

Therefore, e-cigarettes will soon be added to the list of products that include banned addictive substances and precursors.

 

According to a report from the Ministry of Health of Laos in October, tobacco-related diseases were the leading cause of death in the country in 2019, accounting for approximately 65% of all deaths. It is estimated that tobacco annually causes hundreds of thousands of chronic illnesses and results in the deaths of 6,700 people.

 

The use of tobacco among young people in Laos, particularly e-cigarettes, is steadily growing and becoming increasingly prevalent. As a result, the Ministry of Health expresses concern that without timely measures to restrict it, the country will soon face a new wave of e-cigarette addiction, which is equally harmful as traditional tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances revision of tobacco law to include synthetic nicotine products, expected to generate $6.3 billion in tax revenue
South Korean Parliament advances tobacco law revision, including synthetic nicotine products, anticipating $630 million tax revenue increase.
Oct.16 by 2FIRSTS.ai
2Firsts Special Report|China’s Nicotine Pouch Manufacturing Goes Global: A Supply Chain Reshaped and Redirected
2Firsts Special Report|China’s Nicotine Pouch Manufacturing Goes Global: A Supply Chain Reshaped and Redirected
China’s nicotine pouch manufacturing expanded rapidly in 2024 but cooled sharply in 2025. Meanwhile, global demand continued to grow strongly, with multinational tobacco companies increasing investment, prompting some Chinese manufacturers to accelerate the shift of production to Southeast Asia and Europe.
Nov.21
PMI Japan Upgrades IQOS ILUMA i One with New Button Layout, Aluminum Base
PMI Japan Upgrades IQOS ILUMA i One with New Button Layout, Aluminum Base
PMI Japan has refreshed its all-in-one heated tobacco device, IQOS ILUMA i One, with upgraded materials and exterior design. Sales begin October 29 via IQOS stores and the official website. The new model retains core features such as auto-start and continuous use, but is not compatible with accessories from the previous version.
Oct.30 by 2FIRSTS.ai
Australian Federal Police Dismantles WA Illegal Tobacco Network Linked to National Syndicate
Australian Federal Police Dismantles WA Illegal Tobacco Network Linked to National Syndicate
Australian Federal Police (AFP) and Western Australia Police seized more than five tonnes of illicit tobacco products in Perth, including over four million cigarettes, about 50,000 vapes, and nearly 900 kilograms of loose-leaf tobacco. Authorities allege the operation, linked to a national organised crime syndicate, aimed to evade around $8 million in Commonwealth excise and taxes.
Oct.31 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
According to Bloomberg, Dubai-based hookah brand owner Advanced Inhalation Rituals (AIR) plans to go public on Nasdaq in the first half of 2026 through a merger with a Cantor Fitzgerald-backed SPAC. The deal values the combined company at USD 1.75 billion under the ticker “AIIR.”
Nov.11